Literature DB >> 21207938

Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties.

Višnja Stepanić1, Sanja Koštrun, Ivica Malnar, Mario Hlevnjak, Kristina Butković, Irena Ćaleta, Marko Dukši, Goran Kragol, Oresta Makaruha-Stegić, Lara Mikac, Jovica Ralić, Iva Tatić, Branka Tavčar, Klara Valko, Selvira Zulfikari, Vesna Munić.   

Abstract

Macrolides with 14- and 15-membered ring are characterized by high and extensive tissue distribution, as well as good cellular accumulation and retention. Since macrolide structures do not fit the Lipinski rule of five, macrolide pharmacokinetic properties cannot be successfully predicted by common models based on data for small molecules. Here we describe the development of the first models for macrolide cellular pharmacokinetics. By comparison of cellular accumulation and retention in six human primary cell cultures of leukocytic and lung origin, as well as in lung carcinoma cell line NCI-H292, this cell line was found to be an adequate representative cell type for modeling macrolide cellular pharmacokinetics. Accumulation and retention in the NCI-H292 cells, as well as various physicochemical properties, were determined for a set of 48 rationally designed basic macrolide compounds. Classification models for predicting macrolide cellular accumulation and retention were developed using relatively easily determined and conceptually simple descriptors: experimentally determined physicochemical parameters ChromlogD and CHI IAM, as well as a calculated number of positively charged atoms (POS). The models were further tested and improved by addition of 37 structurally diverse macrolide molecules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207938     DOI: 10.1021/jm101317f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.

Authors:  Astrid Milić; Vlatka Bencetić Mihaljević; Jovica Ralić; Ana Bokulić; Danijela Nožinić; Branka Tavčar; Boris Mildner; Vesna Munić; Ivica Malnar; Jasna Padovan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-10-10       Impact factor: 2.441

2.  Structure and conformational analysis of spiroketals from 6-O-methyl-9(E)-hydroxyiminoerythronolide A.

Authors:  Ana Čikoš; Irena Ćaleta; Dinko Žiher; Mark B Vine; Ivaylo J Elenkov; Marko Dukši; Dubravka Gembarovski; Marina Ilijaš; Snježana Dragojević; Ivica Malnar; Sulejman Alihodžić
Journal:  Beilstein J Org Chem       Date:  2015-08-19       Impact factor: 2.883

3.  QSAR Models for Predicting Five Levels of Cellular Accumulation of Lysosomotropic Macrocycles.

Authors:  Ulf Norinder; Vesna Munic Kos
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

4.  Evaluating the Viability of Successive Ring-Expansions Based on Amino Acid and Hydroxyacid Side-Chain Insertion.

Authors:  Aggie Lawer; Ryan G Epton; Thomas C Stephens; Kleopas Y Palate; Mahendar Lodi; Emilie Marotte; Katie J Lamb; Jade K Sangha; Jason M Lynam; William P Unsworth
Journal:  Chemistry       Date:  2020-09-11       Impact factor: 5.236

5.  Epigenetic Modifications, and Alterations in Cell Cycle and Apoptosis Pathway in A549 Lung Carcinoma Cell Line upon Exposure to Perfluoroalkyl Substances.

Authors:  Musarrat Jabeen; Muhammad Fayyaz; Joseph Irudayaraj
Journal:  Toxics       Date:  2020-11-23

6.  Retargeting azithromycin analogues to have dual-modality antimalarial activity.

Authors:  Amy L Burns; Brad E Sleebs; Ghizal Siddiqui; Amanda E De Paoli; Dovile Anderson; Benjamin Liffner; Richard Harvey; James G Beeson; Darren J Creek; Christopher D Goodman; Geoffrey I McFadden; Danny W Wilson
Journal:  BMC Biol       Date:  2020-09-29       Impact factor: 7.431

7.  A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides.

Authors:  Mihaela Peric; Dijana Pešić; Sulejman Alihodžić; Andrea Fajdetić; Esperanza Herreros; Francisco Javier Gamo; Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Santiago Ferrer-Bazaga; María S Martínez; Domingo Gargallo-Viola; Amanda Mathis; Albane Kessler; Mihailo Banjanac; Jasna Padovan; Vlatka Bencetić Mihaljević; Vesna Munic Kos; Mirjana Bukvić; Vesna Eraković Haber; Radan Spaventi
Journal:  Br J Pharmacol       Date:  2020-12-16       Impact factor: 9.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.